| Dr Amanda B Gorsline, OD | |
|
1669 Hamilton Rd, Suite 200, Okemos, MI 48864-1956 | |
| (517) 349-4743 | |
| (517) 349-0096 |
| Full Name | Dr Amanda B Gorsline |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 22 Years |
| Location | 1669 Hamilton Rd, Okemos, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417935925 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 4901004143 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Meridian Eye Care Pc | 0042234635 | 2 |
News Archive
DST Health Solutions, LLC, a leading provider of technology solutions and services to greater than 250 health plans, integrated delivery systems, and health care providers representing greater than 20 million members, today announced the execution of a contract to provide administration operations, care management, and business analytics to Thrive Health Plans, Inc., a Washington D.C.-based managed care organization which operates under the name Trusted Health Plan.
Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Lexicomp has been selected by the University Health Network (UHN) as the drug information resource for its four hospitals located in Toronto, Canada.
University of Maryland School of Medicine researchers have identified two genes associated with binge drinking that may open doors to new, more effective treatments for excessive alcohol drinking. The scientists found that manipulating two receptors in the brain, GABA receptors and toll-like receptor 4 (TLR4), "caused profound reduction" of binge drinking for two weeks in rodents that had been bred and trained to drink excessively. The study was published online the week of Feb. 28 in the journal the Proceedings of the National Academy of Sciences.
Harbour Antibodies BV, an Erasmus MC spin-off company, announced today the completion of a non-exclusive research and licence agreement with Eli Lilly and Company, a global pharmaceutical company, to generate and develop human therapeutic antibodies comprising immunoglobulin heavy and light chains(H2L2) using one of Harbour's transgenic mouse antibody discovery platforms.
› Verified 8 days ago
| Provider Name | Meridian Eye Care Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1881754406 PECOS PAC ID: 0042234635 Enrollment ID: O20060123000387 |
News Archive
DST Health Solutions, LLC, a leading provider of technology solutions and services to greater than 250 health plans, integrated delivery systems, and health care providers representing greater than 20 million members, today announced the execution of a contract to provide administration operations, care management, and business analytics to Thrive Health Plans, Inc., a Washington D.C.-based managed care organization which operates under the name Trusted Health Plan.
Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Lexicomp has been selected by the University Health Network (UHN) as the drug information resource for its four hospitals located in Toronto, Canada.
University of Maryland School of Medicine researchers have identified two genes associated with binge drinking that may open doors to new, more effective treatments for excessive alcohol drinking. The scientists found that manipulating two receptors in the brain, GABA receptors and toll-like receptor 4 (TLR4), "caused profound reduction" of binge drinking for two weeks in rodents that had been bred and trained to drink excessively. The study was published online the week of Feb. 28 in the journal the Proceedings of the National Academy of Sciences.
Harbour Antibodies BV, an Erasmus MC spin-off company, announced today the completion of a non-exclusive research and licence agreement with Eli Lilly and Company, a global pharmaceutical company, to generate and develop human therapeutic antibodies comprising immunoglobulin heavy and light chains(H2L2) using one of Harbour's transgenic mouse antibody discovery platforms.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amanda B Gorsline, OD 2764 Moyer Rd, Williamston, MI 48895-9569 Ph: (517) 655-7072 | Dr Amanda B Gorsline, OD 1669 Hamilton Rd, Suite 200, Okemos, MI 48864-1956 Ph: (517) 349-4743 |
News Archive
DST Health Solutions, LLC, a leading provider of technology solutions and services to greater than 250 health plans, integrated delivery systems, and health care providers representing greater than 20 million members, today announced the execution of a contract to provide administration operations, care management, and business analytics to Thrive Health Plans, Inc., a Washington D.C.-based managed care organization which operates under the name Trusted Health Plan.
Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Lexicomp has been selected by the University Health Network (UHN) as the drug information resource for its four hospitals located in Toronto, Canada.
University of Maryland School of Medicine researchers have identified two genes associated with binge drinking that may open doors to new, more effective treatments for excessive alcohol drinking. The scientists found that manipulating two receptors in the brain, GABA receptors and toll-like receptor 4 (TLR4), "caused profound reduction" of binge drinking for two weeks in rodents that had been bred and trained to drink excessively. The study was published online the week of Feb. 28 in the journal the Proceedings of the National Academy of Sciences.
Harbour Antibodies BV, an Erasmus MC spin-off company, announced today the completion of a non-exclusive research and licence agreement with Eli Lilly and Company, a global pharmaceutical company, to generate and develop human therapeutic antibodies comprising immunoglobulin heavy and light chains(H2L2) using one of Harbour's transgenic mouse antibody discovery platforms.
› Verified 8 days ago
Deltavision Optical Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2333 Jolly Rd, Okemos, MI 48864 Phone: 517-381-2000 Fax: 517-381-2006 | |
James E. Budge, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5100 Marsh Rd Ste H, Okemos, MI 48864 Phone: 517-349-0150 Fax: 517-349-0157 | |
Dr. Terri A Wolf, D.O. Optometrist Medicare: Medicare Enrolled Practice Location: 1669 Hamilton Rd, Suite 200, Okemos, MI 48864 Phone: 517-349-4743 Fax: 517-349-0096 | |
Ellen Mary Dohr, OD Optometrist Medicare: Medicare Enrolled Practice Location: 2333 Jolly Rd, Okemos, MI 48864 Phone: 517-381-2000 Fax: 517-381-2006 | |
Diana Stewart, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2333 Jolly Rd, Okemos, MI 48864 Phone: 517-381-2000 | |
Mrs. Jennifer Mckinnon, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1982 W Grand River Ave, Okemos, MI 48864 Phone: 517-349-0784 | |
Dr. Natasha Nacole Potts, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5110 Times Square Pl, Okemos, MI 48864 Phone: 517-381-8314 Fax: 517-381-8328 |